Review of Immunotherapy Landscape and Importance of Biomarkers

Get in Touch

Our Locations

Review of Immunotherapy Landscape and Importance of Biomarkers

Critical next steps to optimize your clinical trial design

Immunotherapies provide huge potential to fight against cancer. This presentation provides an overview of the immunotherapy landscape and growth of trials, lessons learned from past trials, as well as selecting the appropriate biomarker strategy to optimize trial design.

Author:
Victor Weigman, Ph.D., Director Translational Genomics

Related Thought Leaders Insights

Scientific Poster

Robust performance of single-cell multiomic analysis (CITE-Seq) demonstrated across multiple locations, replicates, and donors on challenging cryopreserved PBMC and BMMC samples

Q² Solutions is the first and only service provider to achieve the exclusive certified service partnership for CITE-Seq scRNA-Seq with BioLegend. Describes CITE-Seq performance expectations for...

Brochure

Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Factsheet

CNS Biomarkers

Rules-Based Medicine, a Q² Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...